Significant agreements (Details) |
1 Months Ended |
|---|---|
|
Jan. 31, 2020
patient
| |
| Bristol-Myers Squibb Company | |
| Significant agreements | |
| Number of patients | 125 |
| X | ||||||||||
- Definition It represents number of additional Cohort of patients with anti PDI failed melanoma. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|